Women with Osteopenia not Advised to Take Fosamax as Treatment

Women with osteopenia or pre-osteoporosis need not to take the osteoporosis drug Fosamax to prevent bone loss, according to a product and service organization. Fosamax has been a controversial prescription drug in the market. Patients claimed that it has been causing them to suffer broken bones and jaw bone death. However, medical specialists suggested people with bone loss problems should include proper diet and exercise. A sufficient intake of calcium and vitamin D helps develop stronger bones.


Fosamax belongs to a class of drugs called biophosphonates. However, there have been thousands of lawsuits filed against the maker of Fosamax, thus making it the most embattled prescription drug in the market. You may read Consumer Reports Does Not Recommend Fosamax As a Treatment for Osteopenia for the full story. 

Create your free website at Beep.com
The responsible person for the content of this web site is solely
the webmaster of this website, approachable via this form!